0000000000467651

AUTHOR

Uri Kopylov

showing 3 related works from this author

Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study

2020

The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled in the study. The cumulative incidence of SARS-CoV-2 infection in patients with IBD vs. the general population was 0.406% and 0.402% cases, respectively. Twenty-three patients (…

medicine.medical_specialtyPopulationlcsh:MedicineInflammatory bowel diseaseArticledrugslaw.invention03 medical and health sciences0302 clinical medicinelawinflammatory bowel diseaseInternal medicinemedicineCumulative incidenceeducationeducation.field_of_studyimmunosuppressionbusiness.industryIncidence (epidemiology)lcsh:RCOVID-19General Medicinemedicine.diseaseIntensive care unitdigestive system diseasesPneumonia030220 oncology & carcinogenesisCohort030211 gastroenterology & hepatologybusinessCohort studyJournal of Clinical Medicine
researchProduct

Postoperative complications and waiting time for surgical intervention after radiologically guided drainage of intra-abdominal abscess in patients wi…

2021

Abstract Background In patients with active Crohn’s disease (CD), treatment of intra-abdominal abscess usually comprises antibiotics and radiologically guided percutaneous drainage (PD) preceding surgery. The aim of this study was to investigate the risk of postoperative complications and identify the optimal time interval for surgical intervention after PD. Methods A multicentre, international, retrospective cohort study was carried out. Details of patients with diagnosis of CD who underwent ultrasonography- or CT-guided PD were retrieved from hospital records using international classification of disease (ICD-10) diagnosis code for CD combined with procedure code for PD. Clinical variable…

PercutaneousAcademicSubjects/MED00910SURGERY:Digestive System Diseases::Gastrointestinal Diseases::Gastroenteritis::Inflammatory Bowel Diseases::Crohn Disease [DISEASES]:Otros calificadores::Otros calificadores::/complicaciones [Otros calificadores]0302 clinical medicineCrohn DiseaseRetrospective StudieAbscess:Bacterial Infections and Mycoses::Infection::Suppuration::Abscess::Abdominal Abscess [DISEASES]PREOPERATIVE OPTIMIZATIONRISKMortality rateAbscessosAbdominal AbscessGeneral Medicine:enfermedades del sistema digestivo::enfermedades gastrointestinales::gastroenteritis::enfermedad inflamatoria intestinal::enfermedad de Crohn [ENFERMEDADES]3. Good healthWaiting List030220 oncology & carcinogenesisCohortPERCUTANEOUS DRAINAGEDrainage030211 gastroenterology & hepatologyOriginal ArticleFemaleAcademicSubjects/MED00010HumanAdultmedicine.medical_specialtyAbdominal AbscessWaiting Lists:infecciones bacterianas y micosis::infección::supuración::absceso::absceso abdominal [ENFERMEDADES]03 medical and health sciencesmedicineHumans:Other subheadings::Other subheadings::/diagnostic imaging [Other subheadings]Retrospective StudiesAgedbusiness.industryAbdominal Absce:Otros calificadores::Otros calificadores::/diagnóstico por imagen [Otros calificadores]Retrospective cohort studyIntra-abdominal AbscessOdds ratiomedicine.diseaseIntestins - Inflamació - ComplicacionsSurgerybusiness:Other subheadings::Other subheadings::/complications [Other subheadings]INFLAMMATORY-BOWEL-DISEASE
researchProduct

Dataset related to article "Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study"

2021

This record contains raw data related to article “Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study" The impact of COVID-19 on inflammatory bowel disease (IBD) patients under pharmacological immunosuppression is still not clearly understood. We investigated the incidence of COVID-19 and the impact of immunosuppression and containment measures on the risk of SARS-CoV-2 infection in a large IBD cohort, from a multicenter cohort from 21st of February to 30th of June, 2020. Ninety-seven patients with IBD (43 UC, 53 CD, one unclassified IBD) and concomitant COVID-19 over a total of 23,879 patients with IBD were enrolled …

researchProduct